VYLOMA
Google image searchProduct monograph
Active ingredient
imiquimod, 3.75 %/W/W
DIN: 02365561
Dosage form(s): CREAM
Route(s) of administration: TOPICAL
Schedule: Prescription
Company: BAUSCH HEALTH, CANADA INC.
Date: 02-JUL-2019
ATC:
- D06 — ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE (ATC, ATC/DDD, )
- D06B — CHEMOTHERAPEUTICS FOR TOPICAL USE (ATC, ATC/DDD)
- D06BB — Antivirals (ATC, ATC/DDD)
- D06BB10 — IMIQUIMOD (ATC/DDD)
Reference brand drug: Aldara, Vyloma, Zyclara
Pharmaceutical standard: MFR
